PATENT CLAIM ANALYSIS

Application Number: 15989008
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["544", "242000"]

Abstract:
Described herein are pyrimidinyl-pyridyloxy-naphthyl compounds with inositol requiring enzyme 1 (IRE1) modulation activity or function having the Formula I or I′ structure: or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I or I′ compounds, as well as methods of using such IRE1 modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.

Claim (Index 7):
The compound of  claim 2 , or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, wherein the compound is of the Formula Ik: wherein R 10a  and R 10b  are independently H, F or \u2014CH 3 .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.46154
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14748990', '15187854', '14670088', '13637127', '16312061']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8065928897213969
- 35 USC 102 Novelty (BERT): 0.5187043948027302
- Combined Prediction Score: 0.7778040402295302
- Mean Citation Score: 324.014682
- Max Citation Score: 328.42313
- Similarity Product: 235.1955021765864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test